<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Big step toward a fair pathway for biosimilars</title>
	<atom:link href="http://iambiotech.org/2009/07/31/big-step-toward-a-fair-pathway-for-biosimilars/feed/" rel="self" type="application/rss+xml" />
	<link>http://iambiotech.org/2009/07/31/big-step-toward-a-fair-pathway-for-biosimilars/</link>
	<description></description>
	<lastBuildDate>Thu, 06 May 2010 14:04:36 -0400</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: I Am Biotech: Discover. Share. Discuss.</title>
		<link>http://iambiotech.org/2009/07/31/big-step-toward-a-fair-pathway-for-biosimilars/comment-page-1/#comment-9791</link>
		<dc:creator>I Am Biotech: Discover. Share. Discuss.</dc:creator>
		<pubDate>Fri, 18 Sep 2009 18:54:28 +0000</pubDate>
		<guid isPermaLink="false">http://iambiotech.org/?p=3158#comment-9791</guid>
		<description>[...] about biosimilars, which claims that a 12 year exclusivity period for biologics (which received strong bipartisan support in both the House and Senate) is &#8220;unnecessarily lengthy&#8221; and would deprive patients [...]</description>
		<content:encoded><![CDATA[<p>[...] about biosimilars, which claims that a 12 year exclusivity period for biologics (which received strong bipartisan support in both the House and Senate) is &#8220;unnecessarily lengthy&#8221; and would deprive patients [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
